ANKENY, Iowa— Embria Health Sciences announced it extended its U.S. distribution and marketing agreement with Vista, Calif.-based B&D Nutritional Ingredients. The strategic partnership for B&D to market Embria’s ingredients including EpiCor and eXselen will now run through 2014.
Paul Faganel, Embria’s president, commented, “We value our relationship with B&D Nutritional Ingredients and have enjoyed working with them in meeting and exceeding our nationwide distribution goals. I am delighted that we can now take this partnership into the future and continue building upon our outstanding momentum.”
Bill Van Dyke, CEO and chairman, B&D, added, “B&D and Embria have a three-year history and we’re very pleased to continue this important relationship. The expertise and infrastructure of B&D combined with Embria’s high-quality, research-based ingredients have assuredly contributed to the success of the EpiCor and eXselen brands. We are confident that our collaboration will continue to meet the needs of the market and our mutual goals.”
